Author
@7Innovator 7Innovator
Disciplined disruptive-growth analyst who DCFs innovators and admits when they're overpriced
Publishes fundamental theses and valuation models (DCF, ROIC
trader score
+1.64
hit rate
60%
mean α
+0.69%
signals 14d
32
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 60% hit rate, +0.69% mean alpha, trader score +1.64. Their last-14d mentions, direction-adjusted, have moved -5.6% since posting (mean over 27 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-10-15 | RKLB | @7Innovator | +0.65 | Consider buying RKLB near $45 for attractive long-term returns. — Explicitly recommends considering a buy at the author's $45 target despite the Neutron delay. | -4.8% | tweet ↗ |
| 2026-10-15 | RKLB | @7Innovator | +0.65 | Consider buying RKLB near $45 for attractive long-term returns. — Explicitly recommends considering a buy at $45 and maintains expectations for three 2027 launches. | -4.8% | tweet ↗ |
| 2026-10-15 | RKLB | @7Innovator | +0.65 | Consider buying RKLB near $45 for attractive long-term returns. — Explicit buy consideration is tied to a $45 price and a long-term return thesis. | -4.8% | tweet ↗ |
| 2026-10-15 | RKLB | @7Innovator | +0.65 | Consider buying RKLB near $45 for attractive long-term returns. — Explicit buy consideration is tied to a $45 price and unchanged 2027 launch expectations. | -4.8% | tweet ↗ |
| 2026-10-15 | RKLB | @7Innovator | +0.65 | Consider buying RKLB near $45 for attractive long-term returns. — Explicit buy consideration is tied to a $45 price and unchanged 2027 launch expectations. | -4.8% | tweet ↗ |
| 2026-10-15 | RKLB | @7Innovator | +0.65 | Consider buying RKLB near $45 for attractive long-term returns. — Explicit buy consideration is tied to a $45 price and unchanged 2027 launch expectations. | -4.8% | tweet ↗ |
| 2026-10-15 | RKLB | @7Innovator | +0.65 | Consider buying RKLB near $45 for attractive long-term returns. — Explicit buy consideration is tied to a $45 price and unchanged 2027 launch expectations. | -4.8% | tweet ↗ |
| 2026-10-15 | RKLB | @7Innovator | +0.70 | Consider buying RKLB near $45 for attractive investment returns. — Calls $45 a very good buying price as shares approach the author's target. | -4.8% | tweet ↗ |
| 2026-10-14 | VEEV | @7Innovator | +0.70 | Recaps three prior Veeva recommendations now up 77%–86% and repeats the original valuation thesis. | +8.6% | tweet ↗ |
| 2026-10-14 | · | @7Innovator | · | Endorses a framework that AI scaling is constrained by electricity, water, land and politics. | · | tweet ↗ |
| 2026-10-13 | · | @7Innovator | · | Fusion has substantial progress and funding but commercial scale remains over a decade away. | · | tweet ↗ |
| 2026-10-09 | · | @7Innovator | · | Commentary says companies are narrowing quantum-computing efforts to one or two approaches. | · | tweet ↗ |
| 2026-10-09 | PANW | @7Innovator | +0.45 | Cybersecurity demand is bullish, while chip inventory and nuclear delays threaten AI infrastructure growth. | -9.1% | tweet ↗ |
| 2026-10-09 | AMD | @7Innovator | -0.35 | Cybersecurity demand is bullish, while chip inventory and nuclear delays threaten AI infrastructure growth. | -15.0% | tweet ↗ |
| 2026-10-09 | OKLO | @7Innovator | -0.50 | Cybersecurity demand is bullish, while chip inventory and nuclear delays threaten AI infrastructure growth. | -24.1% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.